ALHC vs MDGL: fair value comparison
Alignment Healthcare, Inc. and Madrigal Pharmaceuticals, Inc. · Updated 2026-10-19
ALHC is still awaiting a full valuation verdict under our six-validated-windows standard. MDGL's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, ALHC currently ranks higher by quality score.
| ALHC | MDGL | |
|---|---|---|
| Verdict | Awaiting full valuation | Awaiting full valuation |
| Last price | $8.28 | $449.74 |
| 12-month range | $7.54–$24.56 | $412.35–$602.83 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #198 of 301 Healthcare | #200 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Moderate | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | High | — |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Downtrend | Mixed |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: ALHC fair value analysis · MDGL fair value analysis